Since apoC‐III is expressed in both the intestine and the liver, it is unclear whether the inhibition of intestinal TAG secretion in the apoC‐III Tg mice is due directly to its expression in intestine, or indirectly due to expression in liver and subsequent stimulation of VLDL synthesis and plasma hypertriglyceridemia. Here, APOC3 is linked to hypertriglyceridemia.